pharmacoeconomic analysis

It was the first-in-Russia clinical and economic expertise of the micafungin (Mycamin) use in the treatment of adult patients with invasive candidiasis in intensive care units (ICUs). Using simulation methods, a total cost considering treatment …

Invasive candidiasis is a third or fourth cause of sepsis in intensive care units (ICUs). Clinical and pharmacoeconomic study of treatment for invasive candidiasis was first performed using mathematical modeling in Russian economic environment. ICU …

Pharmacoeconomic studies have become an integral part of evidence based medicine at nowadays. However, difficulties in standardization of pharmaeconomical analysis methods and problems with lifelong therapy of chronic pathologic processes …

Very-low-birth weight preterm infants (<1500 g) are at high risk for invasive candidiasis. The prospective randomized controlled clinical trial comparing efficacy of 2 doses of fluconazole (3 and 6 mg/kg) in the prophylaxis of invasive candidiasis …